Equities Analysts Set Expectations for CME Group Inc.’s Q3 2021 Earnings (NASDAQ:CME)

CME Group Inc. (NASDAQ:CME) – Research analysts at Oppenheimer decreased their Q3 2021 earnings per share (EPS) estimates for CME Group in a research report issued on Tuesday, October 12th. Oppenheimer analyst O. Lau now forecasts that the financial services provider will post earnings per share of $1.55 for the quarter, down from their previous forecast of $1.68. Oppenheimer also issued estimates for CME Group’s Q1 2022 earnings at $1.77 EPS, Q2 2022 earnings at $1.72 EPS, Q3 2022 earnings at $1.75 EPS, Q4 2022 earnings at $1.87 EPS and FY2023 earnings at $7.53 EPS.

Other analysts have also recently issued reports about the company. Piper Sandler reiterated a “buy” rating and issued a $230.00 price target on shares of CME Group in a research report on Friday, October 1st. Morgan Stanley lowered their price target on CME Group from $229.00 to $217.00 and set an “equal weight” rating on the stock in a research report on Friday, October 8th. Atlantic Securities upgraded CME Group from a “neutral” rating to an “overweight” rating and set a $230.00 price target on the stock in a research report on Tuesday, September 14th. Berenberg Bank restated a “hold” rating on shares of CME Group in a report on Wednesday, September 15th. Finally, TheStreet cut CME Group from a “b” rating to a “c+” rating in a report on Wednesday, August 18th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, CME Group has a consensus rating of “Hold” and an average target price of $211.38.

Shares of NASDAQ:CME opened at $204.26 on Thursday. The business’s fifty day moving average price is $198.24 and its two-hundred day moving average price is $206.47. CME Group has a fifty-two week low of $146.89 and a fifty-two week high of $221.82. The stock has a market capitalization of $73.36 billion, a price-to-earnings ratio of 38.18 and a beta of 0.43. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 28th. The financial services provider reported $1.64 earnings per share for the quarter, beating analysts’ consensus estimates of $1.59 by $0.05. CME Group had a return on equity of 8.33% and a net margin of 41.64%. The firm had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.17 billion.

Several institutional investors have recently made changes to their positions in the business. Solstein Capital LLC bought a new position in shares of CME Group during the first quarter worth about $28,000. Capital Analysts LLC grew its holdings in shares of CME Group by 370.0% during the first quarter. Capital Analysts LLC now owns 188 shares of the financial services provider’s stock worth $38,000 after buying an additional 148 shares in the last quarter. RE Advisers Corp bought a new position in shares of CME Group during the second quarter worth about $38,000. Glassman Wealth Services grew its holdings in shares of CME Group by 54.0% during the second quarter. Glassman Wealth Services now owns 191 shares of the financial services provider’s stock worth $41,000 after buying an additional 67 shares in the last quarter. Finally, Eagle Bay Advisors LLC bought a new position in shares of CME Group during the second quarter worth about $52,000. Institutional investors own 86.19% of the company’s stock.

In other CME Group news, insider Sean Tully sold 5,000 shares of the stock in a transaction dated Tuesday, August 24th. The stock was sold at an average price of $200.20, for a total value of $1,001,000.00. Following the completion of the sale, the insider now directly owns 23,479 shares in the company, valued at $4,700,495.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Martin J. Gepsman sold 1,000 shares of the stock in a transaction dated Monday, August 23rd. The stock was sold at an average price of $201.37, for a total value of $201,370.00. The disclosure for this sale can be found here. Insiders have sold 9,000 shares of company stock worth $1,786,150 in the last ninety days. 0.30% of the stock is currently owned by insiders.

The company also recently declared a quarterly dividend, which was paid on Monday, September 27th. Stockholders of record on Friday, September 10th were paid a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 1.76%. The ex-dividend date of this dividend was Thursday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 53.57%.

About CME Group

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

Further Reading: Why is the price-sales ratio important?

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.